FDA Inspection 1222051 — Aft Pharmaceuticals Limited
The FDA completed an inspection of Aft Pharmaceuticals Limited on October 20, 2023 in Auckland. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 20, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Auckland (New Zealand)
Additional Details
Sponsor, Contract Research Organization